IKT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||
Also see: IKT Market Cap History IKT YTD Return |
IKT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||
Also see: IKT Market Cap History IKT YTD Return |
IKT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||
+53.25% CAGR Mouse over chart for data details
|
IKT Stock Price Chart |
About Inhibikase Therapeutics Inc |
Inhibikase Therapeutics is a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Co.'s multi-therapeutic pipeline has a primary focus on neurodegeneration and its primary program utilizing IkT-148009, c-Abl inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases. Co. is also developing platform technologies for alternate ways to deliver protein kinase inhibitors in patients. We show 16 historical shares outstanding datapoints in our coverage of IKT's shares outstanding history. Understanding the changing numbers of IKT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like IKT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching IKT by allowing them to research IKT shares outstanding history as well as any other stock in our coverage universe. |
IKT Current Stock Quote |
Free IKT Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
IKT Share Performance |
Shares Outstanding Peers |
Inhibikase Therapeutics (IKT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ILMN Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.